Literature DB >> 19926870

Alterations in lung mast cell populations in patients with chronic obstructive pulmonary disease.

Cecilia K Andersson1, Michiko Mori, Leif Bjermer, Claes-Göran Löfdahl, Jonas S Erjefält.   

Abstract

RATIONALE: Mast cells have important roles in innate immunity and tissue remodeling but have remained poorly studied in inflammatory airway diseases like chronic obstructive pulmonary disease (COPD).
OBJECTIVES: To perform a detailed histological characterization of human lung mast cell populations at different severities of COPD, comparing with smoking and never-smoking control subjects.
METHODS: Mast cells were analyzed in lung tissues from patients with mild to very severe COPD, GOLD I-IV (n = 25, 10 of whom were treated with corticosteroids). Never-smokers and smokers served as controls. The density, morphology, and molecular characteristics of mucosal and connective tissue mast cells (MC(T) and MC(TC), respectively) were analyzed in several lung regions.
MEASUREMENTS AND MAIN RESULTS: In all compartments of COPD lungs, especially at severe stages, the MC(TC) population increased in density, whereas the MC(T) population decreased. The net result was a reduction in total mast cell density. This phenomenon was paralleled by increased numbers of luminal mast cells, whereas the numbers of terminal transferase dUTP nick end labeling (TUNEL)(+) apoptotic mast cells remained unchanged. In COPD lungs, the MC(T) and MC(TC) populations showed alterations in morphology and expression of CD88 (C5a-R), transforming growth factor (TGF)-beta, and renin. Statistically significant correlations were found between several COPD-related mast cell alterations and lung function parameters.
CONCLUSIONS: As COPD progresses to its severe stages, the mast cell populations in the lung undergo changes in density, distribution, and molecular expression. In COPD lungs, these novel histopathological features were found to be correlated to lung function and they may thus have clinical consequences.

Entities:  

Mesh:

Year:  2009        PMID: 19926870     DOI: 10.1164/rccm.200906-0932OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  36 in total

1.  Genome-wide transcriptional profiling reveals connective tissue mast cell accumulation in bronchopulmonary dysplasia.

Authors:  Soumyaroop Bhattacharya; Diana Go; Daria L Krenitsky; Heidi L Huyck; Siva Kumar Solleti; Valerie A Lunger; Leon Metlay; Sorachai Srisuma; Susan E Wert; Thomas J Mariani; Gloria S Pryhuber
Journal:  Am J Respir Crit Care Med       Date:  2012-06-21       Impact factor: 21.405

Review 2.  Update in chronic obstructive pulmonary disease in 2010.

Authors:  Meilan K Han
Journal:  Am J Respir Crit Care Med       Date:  2011-05-15       Impact factor: 21.405

Review 3.  Structure and composition of pulmonary arteries, capillaries, and veins.

Authors:  Mary I Townsley
Journal:  Compr Physiol       Date:  2012-01       Impact factor: 9.090

4.  Lung mast cell density defines a subpopulation of patients with idiopathic pulmonary fibrosis.

Authors:  Seung-Ick Cha; Christine S Chang; Eun Kyung Kim; Jae W Lee; Michael A Matthay; Jeffrey A Golden; Brett M Elicker; Kirk Jones; Harold R Collard; Paul J Wolters
Journal:  Histopathology       Date:  2012-03-06       Impact factor: 5.087

5.  Mast cell phenotype, location, and activation in severe asthma. Data from the Severe Asthma Research Program.

Authors:  Silvana Balzar; Merritt L Fajt; Suzy A A Comhair; Serpil C Erzurum; Eugene Bleecker; William W Busse; Mario Castro; Benjamin Gaston; Elliot Israel; Lawrence B Schwartz; Douglas Curran-Everett; Charity G Moore; Sally E Wenzel
Journal:  Am J Respir Crit Care Med       Date:  2010-09-02       Impact factor: 21.405

Review 6.  Resolution of cell-mediated airways diseases.

Authors:  Carl G Persson; Lena Uller
Journal:  Respir Res       Date:  2010-06-11

7.  Cysteinyl leukotriene 1 receptor expression associated with bronchial inflammation in severe exacerbations of COPD.

Authors:  Jie Zhu; Venkata Bandi; Shengyang Qiu; David J Figueroa; Jilly F Evans; Neil Barnes; Kay K Guntupalli; Peter K Jeffery
Journal:  Chest       Date:  2012-08       Impact factor: 9.410

Review 8.  Mast cells in airway diseases and interstitial lung disease.

Authors:  Glenn Cruse; Peter Bradding
Journal:  Eur J Pharmacol       Date:  2015-05-08       Impact factor: 4.432

9.  A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis.

Authors:  Emma L Beckett; Richard L Stevens; Andrew G Jarnicki; Richard Y Kim; Irwan Hanish; Nicole G Hansbro; Andrew Deane; Simon Keely; Jay C Horvat; Ming Yang; Brian G Oliver; Nico van Rooijen; Mark D Inman; Roberto Adachi; Roy J Soberman; Sahar Hamadi; Peter A Wark; Paul S Foster; Philip M Hansbro
Journal:  J Allergy Clin Immunol       Date:  2013-02-04       Impact factor: 10.793

10.  Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis.

Authors:  Michael H Cho; Merry-Lynn N McDonald; Xiaobo Zhou; Manuel Mattheisen; Peter J Castaldi; Craig P Hersh; Dawn L Demeo; Jody S Sylvia; John Ziniti; Nan M Laird; Christoph Lange; Augusto A Litonjua; David Sparrow; Richard Casaburi; R Graham Barr; Elizabeth A Regan; Barry J Make; John E Hokanson; Sharon Lutz; Tanda Murray Dudenkov; Homayoon Farzadegan; Jacqueline B Hetmanski; Ruth Tal-Singer; David A Lomas; Per Bakke; Amund Gulsvik; James D Crapo; Edwin K Silverman; Terri H Beaty
Journal:  Lancet Respir Med       Date:  2014-02-07       Impact factor: 30.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.